Colorectal cancer screening using protected microRNAs

Journal of Gastrointestinal Oncology, 09/30/2011

Wall NR – The study demonstrate that exosomes prevent the RNase–dependent degradation of miRNAs. Indeed, fecal miRNA–based testing, performed on tumor–exosomes sloughed or shed into the stool, will allow molecular–based diagnosis that in time may also aid in therapy decisions and disease response surveillance leading to better management of colorectal cancer.

Print Article Summary Cat 2 CME Report